ATP III adds to the list of highest-risk patients those with any form of atherosclerotic disease and those with diabetes mellitus. ATP III recommends the intensive treatment of patients with known ...
Objective: To understand the practice patterns and National Cholesterol Education Panel (NCEP) Adult Treatment Panel (ATP) III low-density lipoprotein cholesterol (LDL-C) goal attainment rates after ...
Results from the largest community-based clinical trial to date, involving more than 3000 patients, has shown that adding the cholesterol absorption inhibitor ezetimibe to ongoing stable statin ...
Even though hyperlipidemia heightens vulnerability to MIs and strokes, clinicians are not doing a very good job controlling the condition. Less than half of all patients who qualify for lipid-lowering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results